Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid &bgr;-peptides

By Larner A.J.   Rossor M.N.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1115-1127

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Agents for Alzheimer's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-01 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential in Alzheimer Disease

By  

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

By Castro A.   Martinez A.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 27, 2017-11 ,pp. : 3000-3016

Bentham Science Publishers

Access to resources Recommend Favorite